Rate My Professor Stanley Pang

Employed at Murdoch University since 2015, Pang contributes to the Antimicrobial Resistance and Infectious Diseases Laboratory and collaborates with PathWest Laboratory Medicine-WA at Fiona Stanley Hospital. He has participated in national efforts through the Australian Group on Antimicrobial Resistance (AGAR), including the Australian Enterococcal Sepsis Outcome Programme (AESOP) and Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP), aiding data collection and analysis from 2014 to 2019. Notable publications include 'Emergence and clonal expansion of a qacA-harbouring sequence type 45 lineage of methicillin-resistant Staphylococcus aureus' (2024), 'Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry' (2023), 'Antimicrobial Resistance of and Genomic Insights into Pasteurella multocida Strains Isolated from Australian Pigs' (2023), 'Reversible vancomycin susceptibility within emerging ST1421 Enterococcus faecium strains is associated with rearranged vanA-gene clusters and increased vanA plasmid copy number' (2023), 'Genome-wide association studies reveal candidate genes associated to bacteraemia caused by ST93-IV CA-MRSA' (2021), and 'A three-year whole genome sequencing perspective of Enterococcus faecium sepsis in Australia' (2020). With over 1900 citations and an h-index of 26 on Google Scholar, alongside 68 publications and 1423 citations on ResearchGate, Pang's contributions significantly influence AMR strategies and infectious disease management in Australia.